I genuinely think this is the only thing holding the SP back - i.e. super conservative valuations from brokers. Just wait until the evidence of sales starts to flow! Kaken sold 350k scripts last year - that's $175m right there in US terms!
5% royalties - For sure, we're paying less in royalties than other pharma pay in staff coffee bills!
Also, I just rounded up the war chest to include available money already in the bank prior to the $70m raise.
I genuinely think this is the only thing holding the SP back -...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.8¢ | 35.0¢ | $144.1K | 407.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1465089 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 215186 | 13 |
View Market Depth
| Last trade - 12.49pm 29/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |